Vanguard Group Inc Oric Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,882,055 shares of ORIC stock, worth $20.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,882,055

Previous 2,252,519 27.95%

Holding current value

$20.4 Million

Previous $20.7 Million 91.23%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$8.04 - $16.03 $5.06 Million - $10.1 Million	629,536 Added 27.95%	2,882,055 $39.6 Million
Q4 2023 Feb 14, 2024	SELL	$5.41 - $9.43 $1.82 Million - $3.17 Million	-336,350 Reduced 12.99%	2,252,519 $20.7 Million
Q3 2023 Nov 14, 2023	BUY	$6.05 - $9.28 $4.79 Million - $7.35 Million	791,843 Added 44.06%	2,588,869 $15.7 Million
Q2 2023 Aug 14, 2023	BUY	$4.95 - $8.4 $762,062 - $1.29 Million	153,952 Added 9.37%	1,797,026 $13.9 Million
Q1 2023 May 15, 2023	BUY	$4.26 - $6.75 $412,321 - $653,325	96,789 Added 6.26%	1,643,074 $9.37 Million

Q4 2022 Feb 10, 2023	BUY	$2.41 - $5.89 $480,609 - $1.17 Million	199,423 Added 14.81%	1,546,285 $9.11 Million
Q3 2022 Nov 14, 2022	SELL	$3.28 - $5.24 $219,330 - $350,393	-66,869 Reduced 4.73%	1,346,862 $4.31 Million
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.07 $621,777 - $1.63 Million	-230,288 Reduced 14.01%	1,413,731 $6.33 Million
Q1 2022 May 13, 2022	BUY	$4.54 - $16.1 $63,473 - $225,094	13,981 Added 0.86%	1,644,019 $8.78 Million
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $373,703 - $631,654	31,116 Added 1.95%	1,630,038 $24 Million
Q3 2021 Nov 12, 2021	BUY	$15.9 - $25.22 $5.8 Million - $9.21 Million	365,052 Added 29.59%	1,598,922 $33.4 Million
Q2 2021 Aug 13, 2021	BUY	$17.37 - $25.34 $21.4 Million - $31.3 Million	1,233,870 New	1,233,870 $21.8 Million

Others Institutions Holding ORIC

# of Institutions

113

Shares Held

59.3M

Call Options Held

302K

Put Options Held

7.7K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $280M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Oric Pharmaceuticals, Inc. Transaction History